Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

In this randomized controlled clinical trial, we compare the effects of timolol versus placebo for treatment of myopic regression after LASIK

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Timolol

Criteria

Inclusion Criteria:

• Patients with myopic regression equal or more than 0.5 D with minimum age of 20 years,

• cylinder ≤ -1.00 D,

• corrected distance visual acuity (CDVA) of at least 20/40 were included.

Exclusion Criteria:

• Patients with a history of previous ocular surgery,

• keratoconus or any ectatic corneal disorder,

• keratoconus suspect by topography,

• preoperative corneal opacity,

• any corneal dystrophies,

• presence of pterygium,

• retinal disorders,

• collagen vascular disorders,

• diabetes mellitus,

• glaucoma,

• cataract,

• pregnancy,

• breast feeding

• systemic corticosteroid therapy were excluded.